MedTrace Logo

Assessing the Effectiveness of a Stress Reduction Intervention in Inflammatory Bowel Disease (IBD)

NCT03831750 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2021-05-13

No results posted yet for this study

Summary

The investigators have designed a guided, online, tri-component, stress reduction intervention for participants with inflammatory bowel diseases.

Conditions

  • Inflammatory Bowel Diseases
  • Remission
  • Perceived Stress

Interventions

OTHER

Stress Reduction Intervention

The tri-component intervention is comprised of guided videos for breath-work (5-15 min), stretching (5-15 min), and meditation (10-30 min). The intervention will be delivered online via an access restricted website.

Sponsors & Collaborators

  • University of Alberta

    lead OTHER

Principal Investigators

  • Farhad Peerani, MD · University of Alberta

  • Puneeta Tandon, MD, MSc · University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-22
Primary Completion
2020-03-01
Completion
2021-01-15

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03831750 on ClinicalTrials.gov